Chitosan-based Hemostasis Management Products Market to Double to $3.20B by 2033 – Strategic Revenue Insights (SRI)

Market valued at $1.45B in 2024 grows at 10.4% CAGR driven by biocompatible hemostatic solutions in surgical and trauma ...